Liran Belenzon

Liran Belenzon is CEO of BenchSci, which exponentially increases the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments. Based in Toronto and backed by leading investors including Gradient Ventures, Google’s AI fund, BenchSci now optimizes experimental success in 15 of the top 20 pharmaceutical companies and over 4,300 leading academic centers globally.